Mtar Technologies Limited (MTARTECH)
Investor presentation
AI summary
- FY27 revenue growth guided at 80%, EBITDA margin targeted at 24% ±100 bps
- Strong order inflow of Rs 2895 Cr in Q1FY27, surpassing FY26 total orders
- Civil Nuclear Power segment secured Rs 504 Cr order for Kaiga 5 & 6 projects
- Aerospace & Defence segment progressing volume ramp-up with global and domestic programs
- Clean Energy segment order book at Rs 3431 Cr, with growth driven by fuel cells and data centre solutions
- New greenfield facility commissioning by Q3 FY27 to expand Oil & Gas and Clean Energy capacities
- Focus on operational excellence, capacity expansion, and diversified product portfolio
- Working capital days improved; net working capital management ongoing
- Capital discipline maintained with RoCE at 17.2% and debt-to-equity at 0.45
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 MTARTECH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add MTARTECH to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Mtar Technologies Limited
Important.
The summary above is generated automatically from Mtar Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.